- Amicus Therapeutics ( NASDAQ: FOLD ) is scheduled to announce Q2 earnings results on Thursday, August 4th, before market open.
- The consensus EPS Estimate is -$0.22 (-15.8% Y/Y) and the consensus Revenue Estimate is $85.88M (+11.0% Y/Y).
- Over the last 1 year, FOLD has beaten EPS estimates 50% of the time and has beaten revenue estimates 100% of the time.
- Over the last 3 months, EPS estimates have seen 0 upward revisions and 3 downward. Revenue estimates have seen 1 upward revision and 8 downward.
For further details see:
Amicus Therapeutics Q2 2022 Earnings Preview